Kyowa Kirin’s UK Subsidiary Acquires Global Commercial Rights to Cancer Pain Drug Except Japan and US

June 6, 2012
Kyowa Hakko Kirin announced on June 4 that its UK subsidiary ProStrakan has modified its commercial agreement for cancer pain drug Abstral (overseas brand name; generic name: fentanyl citrate sublingual tablets) with Sweden’s Orexo AB, which discovered the agent. Under...read more